ARTV
Artiva Biotherapeutics, Inc. · Healthcare
RA CAPITAL MANAGEMENT, L.P. bought $413K of Artiva Biotherapeutics, Inc.
Director
Bought$412,777
$9.99Price
41,319Shares
0%Stake
What ARTV did for a copier
- $1,000 copied at Wed, Jul 29 open, $10.69
- $956
- S&P 500, same days
- +3.3%
Measured over 30 trading days, to the Sep 11 close.
RA CAPITAL MANAGEMENT, L.P.'s record
64 other buys with 3 months of prices since 2016: on average −0.2% against the S&P 500, and 23 of 64 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Jul 24. Filed Tue, Jul 28, 5:24 PM ET, after the close. Returns use the Jul 29 open and the Sep 11 close. Not investment advice.